Amy Sullivan - 17 Oct 2022 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Chief Financial Officer
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
Issuer symbol
IOBT
Transactions as of
17 Oct 2022
Net transactions value
$0
Form type
4
Filing time
19 Oct 2022, 16:54:45 UTC
Previous filing
19 Oct 2022
Next filing
20 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +288,152 $0.000000 288,152 17 Oct 2022 Common Stock 288,152 $2.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of these options vest on 10/15/2023, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.